Kawasaki disease (KD; OMIM, 611775), also called Mucocutaneous Lymph Node Syndrome, is an acute, self-limited vasculitis that predominately affects infants and young children[@b1][@b2][@b3]. Although it was first described in Japan in 1967 by the Japanese pediatrician Tomisaku Kawasaki[@b4], the etiology of KD is still not completely clear. The major clinical manifestations of KD include prolonged fever, bilateral non-purulent conjunctivitis, diffuse mucosal inflammation, polymorphous skin rashes, peripheral extremity changes, and cervical lymphadenopathy[@b5]. About 15--25% of untreated cases suffer coronary artery lesions, which is the most serious complication of KD, and makes KD the leading cause of acquired heart disease in children of developed countries[@b6].

Genetic determinants have been suggested to contribute to KD susceptibility. Firstly, the risk of KD in siblings of affected children is ten times higher as compared with the general population[@b7]. Secondly, it is twice as high in children born to parents with a history of KD compared with the general population[@b8]. Thirdly, populations in Asian countries have higher incidence rates of KD than those in Western countries: Japan has the highest annual incidence rate[@b9], followed by Korea[@b10] and Taiwan[@b11], regardless of their residences[@b12]. Accumulating clinical and epidemiological findings suggest that infectious agents trigger inflammatory responses, stirring up host immune dysregulation in part of genetically predisposed individuals[@b13][@b14].

Genome-wide association studies (GWASs) have revolutionized the identification of genomic regions associated with complex diseases[@b15], and so do with KD. Until now, a total of six published GWASs have identified multiple novel single nucleotide polymorphisms (SNPs) associated with KD or coronary artery lesions in Japanese, Europeans, Koreans, Taiwanese and so on[@b16][@b17][@b18][@b19][@b20][@b21]. Among these SNPs, rs2254546, located at an intergenic region between *family with sequence similarity 167, member A* (*FAM167A*, also known as *C8orf13*) and *B lymphoid tyrosine kinase* (*BLK*) at 8p22--23, was firstly discovered to be associated with KD by Onouchi et al.[@b20], who firstly performed a GWAS in a large sample size and then validated this locus in two independent case-control panels of Japanese and transmission disequilibrium tests (TDTs) of other ancestries. Notably, the TDT based on family is considerably advantageous as less confounding caused by population admixture and is more important than case-control study in genetic association analysis[@b22].

The results of KD research on Chinese are very important because of the high prevalence, but as far as we know, there is only one study which has replicated the association between rs2254546 and KD risk on a population from Sichuan province of Southwest China[@b23]. Therefore, we proposed to verify this association on another Chinese population from Zhejiang province of Southeast China. Subsequently, a meta-analysis, combining the current and previously published studies, and applying the method described by Kazeem and Farrall[@b24], was performed to integrate the results from case-control studies and TDTs, and to provide more convincing evidence for this association.

Results
=======

Results of our current case-control study
-----------------------------------------

### Population characteristics

A total of 428 cases and 478 controls participated in our current study. There were 263 (61.45%) males in cases and 294 (61.51%) males in controls, and no statistically significant difference was observed between these two groups in the distribution of gender (Pearson *χ*^2^ = 0.000, *P* = 0.986).

### Association analysis

Among all the participants, 892 samples were genotyped successfully, so that the genotyping call rate of rs2254546 was 98.45%. The distribution of genotypes in controls was in agreement with Hardy-Weinberg equilibrium (HWE, *P* = 0.062) while no significant difference was observed in genotype frequencies between cases and controls (*χ*^2^ = 4.08, *P* = 0.130). As shown in [Table 1](#t1){ref-type="table"}, under the multivariate logistic regression model adjusted for gender, individuals with GG genotype showed a significant association with the increased risk of KD, compared with those carrying AA genotype (odds ratio (OR) = 1.86, 95% confidence interval (95%CI) = 1.01--3.41, *P* = 0.045). The same result was found under the dominant model (OR = 1.83, 95% CI = 1.01--3.33, *P* = 0.048). However, we failed to find the significant association in allelic model (OR = 1.20, 95% CI = 0.96--1.50, *P* = 0.117).

Results of meta-analysis
------------------------

### Study characteristics

After comprehensive searching, two published articles met the inclusion criteria, one GWAS and one replication study respectively[@b20][@b23]. Thus, a total of eight previous reports plus our current study, comprising five case-control studies of 1958 cases, 5615 controls and four TDTs of 503 trios were finally included in this meta-analysis. Of the nine studies, six studies were conducted in Asians, one in Europeans, one in Hispanics and the other one in multi-ethnic population. [Table 2](#t2){ref-type="table"} shows the characteristics of the included studies.

### Combined results of case-control studies and TDTs

No significant evidence of heterogeneity was observed among the five case-control studies and four TDTs (*Q* = 13.00, *P*~heterogeneity~ = 0.112); thus, the fixed-effects model was employed to assess the pooled association between rs2254546 and KD susceptibility. In the overall meta-analysis, the G allele conferred an increased risk of KD compared with the A allele (OR = 1.55, 95% CI = 1.42--1.70, *P* \< 0.001; [Figure 1](#f1){ref-type="fig"}).

Stratified analysis
-------------------

In consideration of our strategy of meta-analysis by integrating case-control studies and TDTs, the data were firstly stratified by study design. As shown in [Table 3](#t3){ref-type="table"}, significant heterogeneity was detected in case-control subgroup but not in TDT subgroup (*Q* = 10.84, *P*~heterogeneity~ = 0.028; *Q* = 0.83, *P*~heterogeneity~ = 0.843). Meanwhile, significant associations were found between the polymorphism and increased KD risk in both case-control and TDT subgroups (OR = 1.57, 95% CI = 1.34--1.85, *P* \< 0.001; OR = 1.35, 95% CI = 1.05--1.74, *P* = 0.018), under random-effects model and fixed-effects model respectively.

We further stratified the data by ethnicity. Because there was less than three studies conducted in Europeans or Hispanics, we performed a meta-analysis in Asian population only. Similarly, we found a significant association between the G allele of rs2254546 and increased KD risk under random-effects model due to the heterogeneity (OR = 1.58, 95% CI = 1.44--1.74, *P* \< 0.001, *Q* = 10.87, *P*~heterogeneity~ = 0.054; [Table 4](#t4){ref-type="table"}).

Sensitivity analysis
--------------------

To evaluate the influence of each study on the overall estimate, sensitivity analysis was performed. A series of pooled ORs with 95% CIs produced similarly before and after eliminating each study at a time, suggesting that our results were robust ([Table 5](#t5){ref-type="table"}).

Cumulative meta-analysis
------------------------

Cumulative meta-analysis was conducted via adding one study at a time in chronological order. Although the cumulative effects tended to be null significant in time sequence, they still kept exceeding the threshold 1.0. Meanwhile, the 95% CIs became increasingly narrower with the accumulation of more data, indicating a progressive improvement in the precision of the estimates ([Figure 2](#f2){ref-type="fig"}).

Publication bias
----------------

Publication bias was firstly assessed by visual inspection of the funnel plot. The dots were nearly symmetrically distributed, suggesting little evidence of publication bias ([Figure 3](#f3){ref-type="fig"}). The result of regression test for funnel plot asymmetry further indicated no publication bias in this meta-analysis (*P* = 0.815).

Discussion
==========

In our current case-control study, individuals carrying GG genotype or GG/GA genotypes of rs2254546 showed significant associations with KD susceptibility, compared with AA genotype. Moreover, the following meta-analysis, integrating five case-control studies and four TDTs, provided better evidence of the significant relationship between the polymorphism and increased KD risk, which was further confirmed by cumulative analysis in chronological order. Since the discrepancy in genetic backgrounds has been implied to be one possible reason for the distinction of diseases or traits in different ethnicities[@b25], and the prevalence of KD is overwhelmingly higher in Asians, it was deemed meaningful to assess the association of rs2254546 with KD risk in Asian ethnicity alone. Besides, sensitivity analysis indicated the stability of the results and little publication bias existed.

These findings are biologically plausible on some level. rs2254546 is located at an intergenic region between *FAM167A* and *BLK* at 8p22--23, a region harboring SNPs associated with several autoimmune diseases, such as systemic lupus erythematosus[@b26][@b27], rheumatoid arthritis[@b28] and systemic sclerosis[@b29][@b30]. *FAM167A* encodes a ubiquitously expressed gene but has not been functionally characterized[@b30]. *BLK* encodes B-lymphoid tyrosine kinase, a Scr family tyrosine kinase expressed primarily in the B-cell lineage, and transduces signal downstream following stimulation of B-cell receptors[@b26][@b31]. Little is known about the function of rs2254546 so far, and all that we know are the statistical associations of this polymorphism with KD[@b20][@b23] or primary Sjogren\'s syndrome[@b32]. However, Onouchi et al.[@b20] have demonstrated that two other SNPs, rs13277113 and rs2736340, which have been repeatedly associated with other autoimmune diseases, were in high linkage disequilibrium with rs2254546 in Japanese (D′ = 0.99, r^2^ = 0.87; D′ = 0.99, r^2^ = 0.91). It has been indicated that the risk A allele of rs13277113 was associated with reduced expression of *BLK* mRNA in transformed B-cell lines[@b26]. Meanwhile, Chang et al. have also provided evidence that the risk T allele of rs2736340 was associated with lower expression of BLK in peripheral blood B cells during the acute stage of KD, and decreased BLK expression in peripheral blood B cells may alter B cell function and predispose individuals to KD[@b33]. All of the above indicate the reasonability of our results. What\'s more, it is well known that most of the variants identified by GWASs cannot be per se causal but imply the probability of being in linkage with the "real" causal variants[@b34], so we can speculate that rs2254546, like the two relevant SNPs, rs2736340 and rs13277113, is possibly the real causal variant, but more likely to be just in linkage equilibrium with the real causal variant.

The current study had its own special advantages. Firstly, we adopted a comprehensive analysis strategy (a case-control study and followed by a meta-analysis) to discern the association between rs2254546 and KD susceptibility; Secondly, in this meta-analysis, significant associations were detected in both case-control and TDT subgroups, which confirmed the statistical consistency of the two study designs. The study power was strongly enhanced by integrating these two study designs together due to the enlargement of sample size. Thirdly, the between-study heterogeneity in the overall meta-analysis was so negligible that these studies were considered compatible. Finally, the results of cumulative analysis, sensitivity analysis and publication bias further provided statistical evidence of the high quality of the meta-analysis.

Despite of the clear advantages we have mentioned above, several limitations should be figured out at the same time. Firstly, our own case-control study failed to replicate the significant association in allelic model, and the relatively small sample size and low statistical power might be taken into account. Secondly, the association between rs2254546 and KD risk is merely on statistical level, so the lack of functional experiments makes its role in KD pathogenesis still an enigma. Thirdly, KD is a complex disease caused by both genetic and environmental factors. However, the insufficient information about the environment limited the further evaluation of gene-environment interaction.

In summary, our case-control study combined with the following meta-analysis might provide convincing evidence for the significant association between rs2254546 polymorphism and KD susceptibility. Fine-mapping and sequencing studies, as well as functional studies are further warranted to identify and validate the potential causal variants.

Methods
=======

Study participants
------------------

This study contained 428 children diagnosed with KD, all of which were unrelated ethnic Han Chinese and were consecutively recruited between April 2009 and September 2012 from Children\'s Hospital, Zhejiang University School of Medicine, China. The diagnosis of KD was based on the 5th revised edition of the guidelines established by the Kawasaki Disease Research Committee in Japan in 2002 (<http://kawasaki-disease.org/diagnostic/>). The controls consisted of 478 gender-matched unrelated healthy Han Chinese children without any evidence of infection, part of which have ever been included in our previous study[@b35]. All the controls were recruited from children who took the entrance physical examination for primary school in Children\'s Hospital, Zhejiang University School of Medicine.

This study was approved by the ethics committee of the Children\'s Hospital, Zhejiang University School of Medicine, and the methods were carried out in accordance with the approved guidelines. Informed consent was obtained from all participants or parents/caregivers of all the subjects who were studied.

Genotyping
----------

Genomic DNA was extracted from 2 ml peripheral blood sample that was collected from each participant, using the RelaxGene Blood System DP319-02 (Tiangen, Beijing, China) according to the manufacturer\'s protocol. The concentration and the optical density of DNA was confirmed by NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, Massachusetts, USA). Genotypes were determined by TaqMan SNP Genotyping Assay (Applied Biosystems, Foster City, CA, USA) as described below, which was performed without knowledge of participants\' disease status. The final reaction volume per well was 5 μL for a 384-well plate, including 20× working stock of SNP Genotyping Assay (0.25 μL), TaqMan Universal PCR Master Mix (2×), No AmpErase UNG (2.5 μL), DNase-free water (1.25 μL), and Template DNA (1 μL). The first two of which were customized by Applied Biosystems. The reaction was carried out with an initial step of 10 minutes at 95°C, which was the optimal temperature for AmpliTaq Gold Enzyme Activation; then followed by 50 cycles of 15 seconds at 92°C and 90 seconds at 60°C. After PCR amplification, allelic discrimination plate read and analysis were performed using Applied Biosystems 7900HT Fast Real-Time PCR System, followed the manufacturer\'s protocol.

For quality control, a 5% random samples were tested twice to assess the reproducibility, with a concordance rate of 100%. A total of 892 samples were genotyped successfully, so that the genotyping call rate of rs2254546 was 98.45%.

Statistical analysis
--------------------

HWE was assessed by the goodness-of --fit *χ*^2^ test for genotypes in the control group. Pearson\'s *χ*^2^ test was applied to estimate the differences in gender and distribution of genotypes between cases and controls. After adjusting for gender, unconditional multivariate logistic regression was employed to estimate ORs and their 95% CIs for the effect of the SNP on KD susceptibility. To avoid the assumption of genetic models, dominant, recessive and additive model were all analyzed respectively. All above statistical analyses were performed in SPSS V13.0 and all *P* values were two-tailed with a significant level of 0.05.

Meta-analysis of rs2254546 in association with KD risk
------------------------------------------------------

To further confirm the association between rs2254546 and KD susce*p*tibility, a meta-analysis combining published literatures and our current study was conducted. We searched various databases including PubMed, EMBASE, ISI Web of Science and Google Scholar up to October 2013 without language restriction, using the keywords 'rs2254546 or *FAM167A-BLK*\' combined with 'Kawasaki disease\'. We further checked five large Chinese biomedical bibliographic databases to expand the coverage of our searches[@b36]. References listed in the retrieved articles and reviews were also scanned for missing information. The included articles had to meet the following criteria: (1) either case-control study or TDT design; (2) availability of allelic frequency necessary for calculating ORs and their 95% CIs; (3) clear definition of KD, either based on the diagnostic criteria from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[@b5], or the diagnostic guidelines for Kawasaki disease (the 5^th^ revised edition, <http://kawasaki-disease.org/diagnostic/>), published by the Kawasaki Disease Research Committee of Japan; (4) studies on humans. When multiple articles had overlapped study participants, the one with more complete design or larger sample size was finally selected.

For each of the eligible studies, the following information was extracted independently by two reviewers (W.W. and J.L.): first author\'s name, year of publication, country, ethnicity of study participants, study design, study type, genotyping method, sample size, frequencies of alleles in case and control group in case-control studies and numbers of transmitted and non-transmitted alleles from heterozygous parents to affected offspring in family-based studies. The Cochran\'s *χ*^2^-based *Q* statistic test was applied to assess between-study heterogeneity. As regard of the p-value cut-off, both the use of a significance level of 0.1 or 0.05 are commonly accepted in this type of test[@b37][@b38]. In this study, we chose 0.1 as the significance p-value cut-off for the heterogeneity. If *P* \< 0.1, a random-effects model, using DerSimonian and Laird method[@b39], was employed to compute the pooled ORs; otherwise, a fixed-effects model, using Mantel-Haenszel method[@b40], was adopted. For the synthesis of case-control studies and TDTs, a method described by Kazeem and Farrall[@b24] was used to obtain a combined estimate of the magnitude of the association. The "Catmap" software[@b41] for this method was downloaded from the comprehensive R archive network <http://www.r-project.org>. On condition that the heterogeneity existed, a meta-regression analysis would be conducted to explore the possible sources of the heterogeneity across studies[@b42]. Stratified analysis was carried out subsequently, on the basis of the suspected sources of heterogeneity reported by the meta-regression analysis. Afterwards, sensitivity analysis was performed to assess the influence of each study on the overall estimate. Cumulative meta-analysis was also conducted by adding studies one at a time in chronological order. Funnel plot and regression test were utilized to assess publication bias. All statistical analyses and figures were performed in R software V2.13.2 and *P* values less than 0.05 were considered statistically significant for all tests except for *Q* test for heterogeneity.
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###### Association between rs2254546 and KD risk in the current study

  Genotype           Cases N (%)   Controls N (%)      OR          95%CI        *P*[†](#t1-fn1){ref-type="fn"}
  ----------------- ------------- ---------------- ---------- ---------------- --------------------------------
  AA                  17 (4.07)      34 (7.17)        Ref.          Ref.                       
  AG                 138 (33.01)    156 (32.91)       1.77       0.95--3.31                 0.073
  GG                 263 (62.92)    284 (59.92)     **1.86**   **1.01--3.41**             **0.045**
  G/A allele                                          1.20       0.96--1.50                 0.117
  Dominant model                                    **1.83**   **1.01--3.33**             **0.048**
  Recessive model                                     1.14       0.87--1.49                 0.347
  Additive model                                      1.19       0.95--1.48                 0.123

^†^The *P* values were adjusted for gender.

The positive results were in bold.

###### The characteristics of included studies in meta-analysis

  First author     Year   Country   Ethnicity   Study design   Study type           Genotyping method           Sample size
  --------------- ------ --------- ----------- -------------- ------------- ---------------------------------- -------------
  Onouchi          2012    Japan      Asian          CC           GWAS       Illumina Human Hap550v3 BeadChip    428/3379
  Onouchi          2012    Japan      Asian          CC        Replication            Invader Assay               470/378
  Onouchi          2012    Japan      Asian          CC        Replication            Invader Assay               284/569
  Onouchi          2012     USA     European        TDT        Replication            Invader Assay                 248
  Onouchi          2012     USA       Asian         TDT        Replication            Invader Assay                 72
  Onouchi          2012     USA     Hispanic        TDT        Replication            Invader Assay                 94
  Onouchi          2012     USA       Mixed         TDT        Replication            Invader Assay                 89
  Yan              2013    China      Asian          CC        Replication     TaqMan SNP Genotyping Assays       358/815
  Current study    2013    China      Asian          CC        Replication     TaqMan SNP Genotyping Assays       418/474

Abbreviations: CC, case-control study; TDT, transmission/disequilibrium test.

###### Meta-analysis of rs2254546 in association with KD risk stratified by study design

                          Case-control      TDT      OR (95%CI)                                                       
  ---------------------- -------------- ----------- ------------ ----- ---------------------------------------------- ----------------------------------------------
  Onouchi (GWAS), 2012      702/154      4866/1892       \-       \-                 1.77 (1.48--2.13)                                      \-
  Onouchi (CC1), 2012       761/179       522/234        \-       \-                 1.91 (1.52--2.38)                                      \-
  Onouchi (CC2), 2012       454/114       808/330        \-       \-                 1.63 (1.28--2.07)                                      \-
  Onouchi (TDT1), 2012         \-           \-           75       60                         \-                                     1.25 (0.89--1.76)
  Onouchi (TDT2), 2012         \-           \-           24       16                         \-                                     1.50 (0.80--2.82)
  Onouchi (TDT3), 2012         \-           \-           21       12                         \-                                     1.75 (0.86--3.56)
  Onouchi (TDT4), 2012         \-           \-           25       19                         \-                                     1.32 (0.72--2.39)
  Yan, 2013                 590/126      1246/384        \-       \-                 1.44 (1.15--1.81)                                      \-
  Current study, 2013       664/172       724/224        \-       \-                 1.19 (0.95--1.50)                                      \-
  Pooled                    3171/745     8166/3064      145       107   1.57 (1.34--1.85)[†](#t3-fn1){ref-type="fn"}   1.35 (1.05--1.74)[‡](#t3-fn2){ref-type="fn"}

^†^Random-effects pooled OR, *P* \< 0.001; *Q* = 10.84, *P*~heterogeneity~ = 0.028.

^‡^Fixed-effects pooled OR, *P* = 0.018; *Q* = 0.83, *P*~heterogeneity~ = 0.843.

###### Meta-analysis of rs2254546 in association with KD risk in Asian population

                          Case-control      TDT               
  ---------------------- -------------- ----------- ---- ---- ----------------------------------------------
  Onouchi (GWAS), 2012      702/154      4866/1892   \-   \-                1.77 (1.48--2.13)
  Onouchi (CC1), 2012       761/179       522/234    \-   \-                1.91 (1.52--2.38)
  Onouchi (CC2), 2012       454/114       808/330    \-   \-                1.63 (1.28--2.07)
  Onouchi (TDT2), 2012         \-           \-       24   16                1.50 (0.80--2.82)
  Yan, 2013                 590/126      1246/384    \-   \-                1.44 (1.15--1.81)
  Current study, 2013       664/172       724/224    \-   \-                1.19 (0.95--1.50)
  Pooled                    3171/745     8166/3064   24   16   1.58 (1.44--1.74)[†](#t4-fn1){ref-type="fn"}

^†^Random-effects pooled OR, *P* \< 0.001; *Q* = 10.87, *P*~heterogeneity~ = 0.054.

###### Sensitivity analysis of allelic model

  Study omitted            *Q*    *P*~heterogeneity~      OR (95%CI)         *P*
  ---------------------- ------- -------------------- ------------------- ---------
  Onouchi (GWAS), 2012    10.32         0.171          1.49 (1.34--1.65)   \<0.001
  Onouchi (CC1), 2012     9.17          0.241          1.49 (1.35--1.65)   \<0.001
  Onouchi (CC2), 2012     12.83         0.076          1.51 (1.31--1.75)   \<0.001
  Onouchi (TDT1), 2012    11.31         0.126          1.58 (1.44--1.73)   \<0.001
  Onouchi (TDT2), 2012    12.98         0.072          1.53 (1.34--1.75)   \<0.001
  Onouchi (TDT3), 2012    12.89         0.075          1.52 (1.34--1.74)   \<0.001
  Onouchi (TDT4), 2012    12.69         0.080          1.54 (1.35--1.76)   \<0.001
  Yan, 2013               12.51         0.085          1.54 (1.33--1.79)   \<0.001
  Current study, 2013     6.76          0.454          1.63 (1.48--1.80)   \<0.001
